Primary Immune Thrombocytopenia (ITP)
Pathophys: thrombocytopenia ...
236
Description

Primary Immune Thrombocytopenia (ITP)

Pathophys: thrombocytopenia d/t auto Ab-mediated megakaryocyte destruction and ↓ plt production

Presentation: Presents w/ mucocutaneous bleeding; defined by isolated plt <100k, dx of exclusion; 10% have ITP + AIHA = Evans Syndrome; BMBx ↑ megakaryocytes (performed in >60yo to r/o MDS); anti-plt Ab testing not useful.

Management:

 • Severe bleeding: plts, IVIG, methylpred 1g/d IV x3d (or dexamethasone 40mg/d x4d), consider romiplostim.

     o If no response in plts, consider Amicar (0.1g/kg/30min→0.5-1g/hr) / tranexamic acid / activated FVII

 • 1st line: dexamethasone 40 mg/d x4d (or prednisone 1 mg/kg/d PO x2-3wk → taper) +/- IVIG 1 g/kg/d IV x 2d

 • 2nd line: rituximab, Nplate (romiplostim), danazol (older women), splenectomy (consider after 6mo-1y, rarely done)



#Primary #Immune #Thrombocytopenia #ITP #idiopathic #hematology #diagnosis #management 
Contributed by

MGH White Book Manual
@MGHWhiteBook
Account created for the MGH Internal Medicine Housestaff Manual "White Book" - https://stk10.github.io/MGH-Docs/WhiteBook-2019-2020.pdf
0 Comments

Related content